Keros Therapeutics
KROS
KROS
81 hedge funds and large institutions have $1.13B invested in Keros Therapeutics in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
20.99% more ownership
Funds ownership: 58.41% → 79.39% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
81
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$60.4M | |
| 2 | +$39.3M | |
| 3 | +$38.4M | |
| 4 |
Alkeon Capital Management
New York
|
+$34.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$24.4M |
Top Sellers
| 1 | -$81.1M | |
| 2 | -$9.57M | |
| 3 | -$3.22M | |
| 4 |
TC
Telemus Capital
Southfield,
Michigan
|
-$775K |
| 5 |
Renaissance Technologies
New York
|
-$536K |